APA (7th ed.) Citation

Barr, P. M., Robak, T., Owen, C., Tedeschi, A., Bairey, O., Bartlett, N. L., . . . Ghia, P. (2018). Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: Extended phase 3 results from RESONATE-2. Haematologica (Roma), 103(9), 1502-1510. https://doi.org/10.3324/haematol.2018.192328

Chicago Style (17th ed.) Citation

Barr, Paul M., et al. "Sustained Efficacy and Detailed Clinical Follow-up of First-line Ibrutinib Treatment in Older Patients with Chronic Lymphocytic Leukemia: Extended Phase 3 Results from RESONATE-2." Haematologica (Roma) 103, no. 9 (2018): 1502-1510. https://doi.org/10.3324/haematol.2018.192328.

MLA (9th ed.) Citation

Barr, Paul M., et al. "Sustained Efficacy and Detailed Clinical Follow-up of First-line Ibrutinib Treatment in Older Patients with Chronic Lymphocytic Leukemia: Extended Phase 3 Results from RESONATE-2." Haematologica (Roma), vol. 103, no. 9, 2018, pp. 1502-1510, https://doi.org/10.3324/haematol.2018.192328.